We’re excited to share that the Q-Centrix abstract, Assessing How Racial Identify Correlates With Time To Surgery Initiation Among Early-Stage Breast Cancer Patients, has been accepted and will be shared as a poster presentation at the American Society of Clinical Oncology (ASCO) Quality Symposium. This thought-provoking study focuses on odds ratios of black breast cancer patients receiving surgery within an optimal timeframe versus those of white breast cancer patients. View it during Poster Session B on October 11.

2025 ASCO Quality Symposium
October 10-11, 2025
Chicago, Illinois

Related Insights


How Market Analytics Transforms Oncology Registry Data Into Actionable Insights
This guide provides an overview of Market Analytics, found in Q-Centrix’s technology stack for oncology data, Q-Apps®: Oncology.


One Assessment, Systemwide Change
Explore how partnering with Q-Centrix for an enterprise assessment led a health system to transform its clinical data management process.

Transforming Oncology Data into Strategy with Market Analytics
Whether you want to monitor campaign effectiveness, identify lost opportunities to competitors, or understand where the market will support growth,…